The DOI matches its Crossref record; 300 of the 300 references it cites were found in a registry or an index.
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Open accessAbstract
Matrix metalloproteinase‐9 (MMP‐9) is a member of the metzincin family of mostly extracellularly operating proteases. Despite the fact that all of these enzymes might be target promiscuous, with largely overlapping catalogs of potential substrates,MMP‐9 has recently emerged as a major and apparently unique player in brain physiology and pathology. The specificity of MMP‐9 may arise from its very local and time‐restricted actions, even when released in the brain from cells of various types, including neurons, glia, and leukocytes. In fact, the quantity of MMP‐9 is very low in the naive brain, but it is markedly activated at the levels of enzymatic activity, protein abundance, and gene expression following various physiological stimuli and pathological insults. Neuronal MMP‐9 participates in synaptic plasticity by controlling the shape of dendritic spines and function of excitatory synapses, thus playing a pivotal role in learning, memory, and cortical plasticity. When improperly unleashed,MMP‐9 contributes to a large variety of brain disorders, including epilepsy, schizophrenia, autism spectrum disorder, brain injury, stroke, neurodegeneration, pain, brain tumors, etc. The foremost mechanism of action of MMP‐9 in brain disorders appears to be its involvement in immune/inflammation responses that are related to the enzyme's ability to process and activate various cytokines and chemokines, as well as its contribution to blood–brain barrier disruption, facilitating the extravasation of leukocytes into brain parenchyma. However, another emerging possibility (i.e., the control of MMP‐9 over synaptic plasticity) should not be neglected. The translational potential of MMP‐9 has already been recognized in both the diagnosis and treatment domains. The most striking translational aspect may be the discovery of MMP‐9 up‐regulation in a mouse model of Fragile X syndrome, quickly followed by human studies and promising clinical trials that have sought to inhibit MMP‐9. With regard to diagnosis, suggestions have been made to use MMP‐9 alone or combined with tissue inhibitor of matrix metalloproteinase‐1 or brain‐derived neurotrophic factor as disease biomarkers. imageMMP‐9, through cleavage of specific target proteins, plays a major role in synaptic plasticity and neuroinflammation, and by those virtues contributes to brain physiology and a host of neurological and psychiatric disorders. This article is part of the60th Anniversary special issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–300 of 300
Suenaga, N., Ichiyama, T., Kubota, M., Isumi, H., Tohyama, J., & Furukawa, S. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.09.011 · Cited by 73
Lakhan, S. E., & Avramut, M. (2012) · Pain Research and Treatment · doi:10.1155/2012/952906 · Cited by 73
Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia
Konopka, A., Grajkowska, W., Ziemiańska, K., Roszkowski, M., Daszkiewicz, P., Rysz, A., Marchel, A., Koperski, Ł., Wilczynski, G. M., & Dzwonek, J. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.09.018 · Cited by 72
Alexander, J. S., Harris, M., Wells, S., Mills, G. M., Chalamidas, K., Ganta, V. C., McGee, J. C., Jennings, M. H., Gonzalez-Toledo, E., & Minagar, A. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510370791 · Cited by 72
Smith, A. C. W., Scofield, M. D., & Kalivas, P. W. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.027 · Cited by 71
Matrix Metalloproteinases and Minocycline: Therapeutic Avenues for Fragile X Syndrome
Siller, S. S., & Broadie, K. S. (2012) · Neural Plasticity · doi:10.1155/2012/124548 · Cited by 71
Mizoguchi, H., Yamada, K., Mouri, A., Niwa, M., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., & Nabeshima, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04623.x · Cited by 71
Boz, C., Özmenoğlu, M., Velioğlu, S., Kılınç, K., Örem, A., Alioğlu, Z., & Altunayoğlu, V. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.01.005 · Cited by 71
Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory
Wright, J. W., Brown, T. E., & Harding, J. W. (2007) · Neural Plasticity · doi:10.1155/2007/73813 · Cited by 71
Kumarasinghe, N., Beveridge, N. J., Gardiner, E. J., Scott, R. J., Yasawardene, S. G., Perera, A., Mendis, J., Suriyakumara, K., Schall, U., & Tooney, P. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000035 · Cited by 71
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation
Vandooren, J., Damme, J. V., & Opdenakker, G. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00009-8 · Cited by 70
Chang, S.-H., Chiang, S., Chiu, C., Tsai, C.-C., Tsai, H.-H., Huang, C., Hsu, T., & Tzang, B. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.049 · Cited by 70
Spinal Matrix Metalloproteinase-9 Contributes to Physical Dependence on Morphine in Mice
Liu, W., Han, Y., Liu, Y., Song, A. A., Barnes, B., & Song, X. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1358-10.2010 · Cited by 70
Oya, K., Kishi, T., & Iwata, N. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2426 · Cited by 69
Caregiver burden in bipolar hypomania and mania: a systematic review.
Beentjes, T., Goossens, P., & Poslawsky, I. (2012) · Perspectives in psychiatric care · doi:10.1111/j.1744-6163.2012.00328.x · Cited by 69
Sellner, J., Simon, F., Meyding‐Lamadé, U., & Leib, S. L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.093 · Cited by 69
Gim, G.-T., Lee, J., Park, E., Sung, Y.-H., Kim, C., Hwang, W.-W., Chu, J., & Min, B.-I. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.09.010 · Cited by 67
Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over‐expressing MMP9
Fragkouli, A., Papatheodoropoulos, C., Georgopoulos, S., Stamatakis, A., Stylianopoulou, F., Tsilibary, E. C., & Tzinia, A. K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07637.x · Cited by 66
Hanzel, C. E., Iulita, M. F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., & Cuello, A. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132282 · Cited by 66
Mroczko, B., Groblewska, M., & Barcikowska, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130647 · Cited by 65
Lorenzl, S., Calingasan, N. Y., Yang, L., Albers, D. S., Shugama, S., Gregorio, J., Krell, H. W., Chirichigno, J. W., JOH, T. H., & Beal, M. F. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:119 · Cited by 65
Kim, G. W., Kim, H.-J., Cho, K.-J., Kim, H.-W., Cho, Y.-J., & Lee, B. I. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.008 · Cited by 63
Takács, E., Nyilas, R., Szepesi, Z., Baracskay, P., Karlsen, B., Røsvold, T., Bjørkum, A. A., Czurkó, A., Kovács, Z., Kékesi, A. K., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.003 · Cited by 63
Górkiewicz, T., Balcerzyk, M., Kaczmarek, L., & Knapska, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00073 · Cited by 63
Self-citation(2014) · PubMed · Cited by 63
Ichiyama, T., Morishima, T., Kajimoto, M., Matsushige, T., Matsubara, T., & Furukawa, S. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31803994a0 · Cited by 62
Brown, T. E., Forquer, M. R., Harding, J. W., Wright, J. W., & Sorg, B. A. (2008) · Synapse · doi:10.1002/syn.20562 · Cited by 61
Opportunities for the Development of Neuroimmune Therapies in Addiction
Ray, L. A., Roche, D. J. O., Heinzerling, K. G., & SHOPTAW, S. J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00012-9 · Cited by 60
Conant, K. E., Lonskaya, I., Szklarczyk, A., Krall, C., Steiner, J. P., Maguire‐Zeiss, K. A., & Seung Taik, L. I. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07153.x · Cited by 59
Association Studies of MMP-9 in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
He, X., Zhang, L., Yao, X., Hu, J., Yu, L., Jia, H., An, R., Liu, Z., & Xu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073777 · Cited by 59
Spolidoro, M., Putignano, E., Munafò, C., Maffei, L., & Pizzorusso, T. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr158 · Cited by 58
Wiera, G., Wozniak, G., Bajor, M., Kaczmarek, L., & Mozrzymas, J. W. (2013) · Hippocampus · doi:10.1002/hipo.22112 · Cited by 57
Mroczko, B., Groblewska, M., Zboch, M., Kulczyńska, A., Koper, O. M., Szmitkowski, M., Kornhuber, J., & Lewczuk, P. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131634 · Cited by 57
Mizoguchi, H., Yamada, K., & Nabeshima, T. (2011) · Biochemistry Research International · doi:10.1155/2011/681385 · Cited by 57
Influence of hippocampectomy on habituation, exploratory behavior, and spatial memory in rats
Wright, J. W., Murphy, E. S., Elijah, I. E., Holtfreter, K. L., Davis, C. J., Olson, M. L., Muhunthan, K., & Harding, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.083 · Cited by 56
Rumbaugh, J. A., Turchan-Cholewo, J. T., Galey, D., Hillaire, C. S., Anderson, C., Conant, K. E., & Nath, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5619fje · Cited by 55
Chan, J. L., Reeves, T. M., & Phillips, L. L. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.015 · Cited by 55
Samochowiec, A., Grzywacz, A., Kaczmarek, L., Bieńkowski, P., Samochowiec, J., Mierzejewski, P., Preuss, U. W., Grochans, E., & Ciechanowicz, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.072 · Cited by 55
Self-citationKaliszewska, A., Bijata, M., Kaczmarek, L., & Kossut, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr303 · Cited by 55
Self-citationDuran‐Vilaregut, J., del Valle, J., Manich, G., Camins, A., Pallàs, M., Vilaplana, J., & Pelegrí, C. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01157.x · Cited by 54
Genetically encoded FRET-based biosensor for imaging MMP-9 activity
Stawarski, M., Rutkowska-Włodarczyk, I., Zeug, A., Bijata, M., Madej, H., Kaczmarek, L., & Włodarczyk, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.033 · Cited by 54
Self-citationNitric oxide‐mediated regulation of ‐amyloid clearance via alterations of MMP‐9/TIMP‐1
Ridnour, L. A., Dhanapal, S., Hoos, M., Wilson, J., Lee, J., Cheng, R. Y. S., Brueggemann, E. E., Hines, H. B., Wilcock, D. M., Vitek, M. P., et al. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12028 · Cited by 54
Niedringhaus, M. S., Chen, X., Dzakpasu, R., & Conant, K. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042631 · Cited by 53
Treatment of the psychiatric problems associated with fragile X syndrome
Hagerman, R. J., & Polussa, J. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000131 · Cited by 52
Regulation of neurogenesis by extracellular matrix and integrins
Stanaszek, L., Gregor, A., & Zalewska, T. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1827 · Cited by 52
Pitkänen, A., Ndode‐Ekane, X. E., Łukasiuk, K., Wilczynski, G. M., Dityatev, A. E., Walker, M. C., Chabrol, E., Dedeurwaerdere, S., Vázquez, N., & Powell, E. M. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00011-6 · Cited by 51
Yushchenko, M., M�der, M., Elitok, E., et al. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0191-4 · Cited by 51
Giraudon, P., Buart, S., Bernard, A., Thomasset, N., & Belin, M. F. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00017-2 · Cited by 51
MMP2-9 Cleavage of Dystroglycan Alters the Size and Molecular Composition of Schwann Cell Domains
Court, F. A., Zambroni, D., Pavoni, E., Colombelli, C., Baragli, C., Figlia, G., Sorokin, L. M., Ching, W., Salzer, J. L., Wrabetz, L. G., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0141-11.2011 · Cited by 50
Kast, R. E., & Halatsch, M. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.04.005 · Cited by 50
Matrix Metalloproteinase-9 Gene and Bipolar Mood Disorder
RYBAKOWSKI, J. K., Skibińska, M., Leszczyńska-Rodziewicz, A., Kaczmarek, L., & Hauser, J. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8072-3 · Cited by 49
Self-citationLi, S., Yu, S., Zhang, C., Shu, H., Liu, S., An, N., Yang, M., Yin, Q., & Yang, H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.009 · Cited by 48
Extracellular proteases in epilepsy
Łukasiuk, K., Wilczynski, G. M., & Kaczmarek, L. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.08.002 · Cited by 47
Self-citationLonskaya, I., Partridge, J. G., Lalchandani, R. R., Chung, A. J., Lee, T., Vicini, S., Hoe, H.-S., Seung Taik, L. I. M., & Conant, K. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069136 · Cited by 46
Łukaszewicz‐Zając, M., Mroczko, B., & Słowik, A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1205-3 · Cited by 46
Wójtowicz, T., & Mozrzymas, J. W. (2010) · Hippocampus · doi:10.1002/hipo.20787 · Cited by 45
Matrix metalloproteinase‐9 is elevated in serum of alcohol abusers
Sillanaukee, P., Kalela, A., Seppä, K., Höyhtyä, M., & Nikkari, S. T. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00975.x · Cited by 44
Smith, A. C. W., Nealey, K. A., Wright, J. W., & Walker, B. M. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.011 · Cited by 44
Stanaszek, L., Sypecka, J., Szymczak, P., Ziemka‐Nałęcz, M., Khrestchatisky, M., Rivera, S., & Zalewska, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022465 · Cited by 43
Kang, S. S., Kook, J. H., Hwang, S., Park, S. H., Nam, S. C., & Kim, J.-K. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.056 · Cited by 42
Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy
Yin, P., Yang, L., Zhou, H. Y., & Sun, R. P. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.013 · Cited by 42
O’Shea, E., Urrutia, A., Green, A. R., & Colado, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.015 · Cited by 42
Aujla, P. K., & Huntley, G. W. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23468 · Cited by 41
Involvement of matrix metalloproteinase-9 in the development of morphine tolerance.
Nakamoto, K., Kawasaki, S., Kobori, T., Fujita-Hamabe, W., Mizoguchi, H., Yamada, K., Nabeshima, T., & Tokuyama, S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.03.006 · Cited by 40
Matrix metalloproteinases in autism spectrum disorders
Abdallah, M. W., & Michel, T. M. (2013) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-1-16 · Cited by 40
MMP-9 microsatellite polymorphism and multiple sclerosis
Fiotti, N., Zivadinov, R., Altamura, N., Nasuelli, D., Bratina, A., Tommasi, M. A., Bosco, A., Locatelli, L., Grop, A., Cazzato, G., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.03.009 · Cited by 39
Bajor, M., Michaluk, P., Gulyássy, P., Kékesi, K. A., Juhász, G. D., & Kaczmarek, L. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07829.x · Cited by 38
Self-citationAssociation of matrix metalloproteinases with MRI indices of brain ischemia and aging
Romero, J. R., Vasan, R. S., Beiser, A., Au, R., Benjamin, E. J., DeCarli, C. S., Wolf, P. A., & Seshadri, S. S. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.004 · Cited by 38
Activity dependent CAM cleavage and neurotransmission
Conant, K. E., Allen, M., & Seung Taik, L. I. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00305 · Cited by 36
Ontogeny of MMPs and TIMPs in the murine neocortex.
Bednarek, N., Clément, Y., Lelièvre, V., Olivier, P., Loron, G., Garnotel, R., & Gressens, P. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181973aee · Cited by 35
Matrix metalloproteinase-9 regulates neuronal circuit development and excitability
Murase, S., Lantz, C. L., Kim, E., Gupta, N., Higgins, R., Stopfer, M., Hoffman, D. A., & Quinlan, E. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9295-y · Cited by 35
Oliveira-Silva, P., Jurgilas, P. B., Trindade, P., Campello‐Costa, P., Perales, J., Savino, W., & Serfaty, C. A. (2007) · NeuroImmunoModulation · doi:10.1159/000110638 · Cited by 35
Bajor, M., & Kaczmarek, L. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0919-6 · Cited by 33
Self-citationQuírico‐Santos, T., Mello, A. L. D. N., Gomes, A. C., Carvalho, L. F. P. P. D. C., de Souza, J. M., & Alves‐Leon, S. V. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.044 · Cited by 33
Wu, X., Liu, B., Ji, S.-M., WU, J.-F., Xu, C., Du, Y., You, X., Li, B., Le, J., XU, H.-L., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3559 · Cited by 32
Sulik, A., & Chyczewski, L. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0058-8 · Cited by 31
Natarajan, R., Harding, J., & Wright, J. (2013) · Journal of Experimental Neuroscience · doi:10.4137/jen.s11381 · Cited by 31
Wiera, G., Wójtowicz, T., Lebida, K., Piotrowska, A., Drulis‐Fajdasz, D., Gomułkiewicz, A., de Carrillo, D. G., Podhorska‐Okołów, M., Capogna, M., Wilczynski, G. M., et al. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.04.005 · Cited by 31
Self-citationWRIGHT, J., Meighan, S. E., MURPHY, E., Holtfreter, K. L., Davis, C. J., OLSON, M., Benoist, C. C., Muhunthan, K., & Harding, J. W. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.006 · Cited by 30
Riboldi, G. M., Nizzardo, M., Simone, C., Falcone, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.07.009 · Cited by 28
Kelly, E. A., Tremblay, M., Gahmberg, C. G., Tian, L., & Majewska, A. K. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23440 · Cited by 27
MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Kaczmarek, L. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811319060010 · Cited by 27
Self-citationLu, L., Tonchev, A. B., Kaplamadzhiev, D. B., Boneva, N. B., Mori, Y., Sahara, S., Ma, D., Nakaya, M., Kikuchi, M., & Yamashima, T. (2008) · Hippocampus · doi:10.1002/hipo.20466 · Cited by 26
The role of matrix metalloproteinase-9 in dementia
Helbecque, N., Hermant, X., Cottel, D., & Amouyel, P. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00905-4 · Cited by 26
Tuning synapses by proteolytic remodeling of the adhesive surface
Shinoe, T., & Goda, Y. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.08.005 · Cited by 24
Phillips, L. L., Chan, J. L., Doperalski, A. E., & Reeves, T. M. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.128237 · Cited by 24
Jedynak, P., Kos, T., Sandi, C., Kaczmarek, L., & Filipkowski, R. K. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.05.009 · Cited by 24
Self-citationDystroglycan controls dendritic morphogenesis of hippocampal neurons in vitro
Bijata, M., Włodarczyk, J., & Figiel, I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00199 · Cited by 23
Safciuc, F., Constantin, A. L., Manea, A., Nicolae, M., Popov, D., Raicu, M., Alexandru, D., & Constantinescu, E. (2007) · Current Neurovascular Research · doi:10.2174/156720207782446351 · Cited by 23
Wiera, G., Szczot, M., Wójtowicz, T., Lebida, K., Koza, P., & Mozrzymas, J. W. (2015) · PubMed · Cited by 23
Han, H., He, X., Tang, J., Liu, W., Liu, K., Zhang, J., Wang, X., Xu, Y., & Chen, X. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.04.026 · Cited by 22
Niedringhaus, M. S., Chen, X., Conant, K. E., & Dzakpasu, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057144 · Cited by 22
Kondratiuk, I., Plucińska, G., Miszczuk, D., Woźniak, G., Szydłowska, K., Kaczmarek, L., Filipkowski, R. K., & Łukasiuk, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128285 · Cited by 21
Self-citationKittaka, S., Hasegawa, S., Ito, Y., Ohbuchi, N., Suzuki, E., Kawano, S., Aoki, Y., Nakatsuka, K., Kudo, K., Wakiguchi, H., et al. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.07.017 · Cited by 21
Alterations in serum MMP and TIMP concentrations following chronic heroin abuse
Kovatsi, L., Batzios, S., Nikolaou, K., Fragou, D., Njau, S., Tsatsakis, A., Karakiulakis, G., & Papakonstantinou, E. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.758681 · Cited by 21
Martins-Oliveira, A., Gonçalves, F. M., Speciali, J. G., Fontana, V., Izidoro‐Toledo, T. C., Belo, V. D. A., Dach, F., & Tanus-Santos, J. E. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.016 · Cited by 21
DP-b99 Modulates Matrix Metalloproteinase Activity and Neuronal Plasticity
Yeghiazaryan, M., Rutkowska-Włodarczyk, I., Konopka, A., Wilczynski, G. M., Melikyan, A., Korkotian, E., Kaczmarek, L., & Figiel, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099789 · Cited by 19
Self-citationYamauchi, K., Yamauchi, T., Mantuano, E., Murakami, K., Henry, K., Takahashi, K., & Campana, W. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075497 · Cited by 15
Heuser, K., Hoddevik, E. H., Taubøll, E., Gjerstad, L., Indahl, U. G., Kaczmarek, L., Berg, P. R., Lien, S., Nagelhus, E. A., & Ottersen, O. P. (2010) · Seizure · doi:10.1016/j.seizure.2010.05.003 · Cited by 13
Self-citationPiccolini, V. M., Avella, D., Bottone, M. G., Bottiroli, G. F., & Bernocchi, G. (2012) · Brain Research · doi:10.1016/j.brainres.2012.09.025 · Cited by 10
Research works printed but not linked: 12
- 10.3109/s10165-009-0198-5 · doi:10.3109/s10165-009-0198-5
- Goldenberg M. M., 2012, Multiple sclerosis review, P. T., 37, 175
- 10.1371/journal.pone.0028499 · doi:10.1371/journal.pone.0028499
- 10.1007/s00296-003-0380-6 · doi:10.1007/s00296-003-0380-6
- 10.2174/138920108783497631 · doi:10.2174/138920108783497631
- 10.1016/j.neuron.2012.10.025 · doi:10.1016/j.neuron.2012.10.025
- Scalea T. M., 2005, Neurotrauma: Evidence‐Based Answers To Common Questions, 3
- 10.1007/s12264-012-1296-5 · doi:10.1007/s12264-012-1296-5
- Szklarczyk A., 2005, Physiology of matrix MMPs and their tissue inhibitors in the brain, Biotech. Int., 17, 15
- 10.1089/neu.2009.0959 · doi:10.1089/neu.2009.0959
- 10.1007/s12035-014-8850-2 · doi:10.1007/s12035-014-8850-2
- Zhao W. J., 2012, Differential expression of MMP‐9 and AQP4 in human glioma samples, Folia Neuropathol., 50, 176
Cited by
BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
Kowiański, P., Lietzau, G., Czuba, E., Waśkow, M., Steliga, A., & Moryś, J. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0510-4 · Cited by 1,359
Colucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207777 · Cited by 991
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R. A., Aisen, P. S., & Turner, R. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0779-0 · Cited by 705
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Scofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Metadata
- Authors
- Vafadari, B., Salamian, A., & Kaczmarek, L.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2016-03-21
- Volume
- 139
- Issue
- S2
- Pages
- 91-114
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1961885071
- Cited by
- 382
- References
- 300
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- EXTRABRAIN 7th Framework Marie Curie European Union Initial Training Network
- Polish Ministry of Science and Higher Education
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.